DC

Decheng Capital Portfolio holdings

AUM $396M
This Quarter Return
+23.46%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$396M
AUM Growth
+$396M
Cap. Flow
-$111M
Cap. Flow %
-27.91%
Top 10 Hldgs %
92.38%
Holding
28
New
1
Increased
3
Reduced
8
Closed
3

Top Buys

1
ACLX icon
Arcellx
ACLX
$4.05M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
$472K
3
RZLT icon
Rezolute
RZLT
$267K
4
KRYS icon
Krystal Biotech
KRYS
$137K

Top Sells

1
LYEL icon
Lyell Immunopharma
LYEL
$100M
2
CYTK icon
Cytokinetics
CYTK
$4.02M
3
RCUS icon
Arcus Biosciences
RCUS
$3.29M
4
LEGN icon
Legend Biotech
LEGN
$2.84M
5
BNTX icon
BioNTech
BNTX
$1.82M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CGON icon
1
CG Oncology
CGON
$2.04B
$166M 41.84% 6,371,669 – –
AARD
2
Aardvark Therapeutics, Inc. Common Stock
AARD
$180M
$53M 13.38% 3,917,299 – –
NUVB icon
3
Nuvation Bio
NUVB
$1.02B
$50.6M 12.78% 25,954,439 – –
UPB
4
Upstream Bio, Inc. Common Stock
UPB
$923M
$36.1M 9.11% 3,285,293 – –
NAMS icon
5
NewAmsterdam Pharma
NAMS
$2.71B
$13.9M 3.52% 770,000 – –
BYSI icon
6
BeyondSpring
BYSI
$69.4M
$10.6M 2.69% 4,531,481 -351,170 -7% -$825K
MRUS icon
7
Merus
MRUS
$4.98B
$9.95M 2.51% 189,098 – –
KRYS icon
8
Krystal Biotech
KRYS
$4.27B
$9.07M 2.29% 66,000 +1,000 +2% +$137K
MLTX icon
9
MoonLake Immunotherapeutics
MLTX
$3.54B
$8.57M 2.16% 181,600 +10,000 +6% +$472K
RVMD icon
10
Revolution Medicines
RVMD
$7.1B
$8.31M 2.1% 226,000 – –
ACRS icon
11
Aclaris Therapeutics
ACRS
$209M
$5.74M 1.45% 4,041,736 – –
LYEL icon
12
Lyell Immunopharma
LYEL
$213M
$5.26M 1.33% 595,466 -11,313,875 -95% -$100M
ACLX icon
13
Arcellx
ACLX
$3.85B
$4.46M 1.13% 547,609 +497,609 +995% +$4.05M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$2.92B
$4.11M 1.04% 143,000 -34,958 -20% -$1.01M
AURA icon
15
Aura Biosciences
AURA
$389M
$3.23M 0.82% 515,555 – –
ZNTL icon
16
Zentalis Pharmaceuticals
ZNTL
$122M
$1.54M 0.39% 1,323,327 -696,435 -34% -$808K
EQ icon
17
Equillium
EQ
$62.2M
$1.4M 0.35% 4,447,308 – –
FDMT icon
18
4D Molecular Therapeutics
FDMT
$288M
$889K 0.22% 239,510 -96,005 -29% -$356K
RCUS icon
19
Arcus Biosciences
RCUS
$1.13B
$811K 0.2% 160,000 -648,789 -80% -$3.29M
ILMN icon
20
Illumina
ILMN
$15.8B
$761K 0.19% 7,979 -3,770 -32% -$360K
LEGN icon
21
Legend Biotech
LEGN
$6.41B
$710K 0.18% 20,000 -80,000 -80% -$2.84M
GRAL
22
GRAIL, Inc. Common Stock
GRAL
$1.18B
$498K 0.13% 9,684 – –
PYXS icon
23
Pyxis Oncology
PYXS
$79.4M
$359K 0.09% 326,810 – –
RZLT icon
24
Rezolute
RZLT
$619M
$267K 0.07% +59,900 New +$267K
NUVB.WS icon
25
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$127K 0.03% 646,057 – –
1
2